Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination
收藏NBER2020-07-01 更新2025-01-04 收录
下载链接：
https://www.nber.org/papers/w27579
下载链接
链接失效反馈官方服务：
资源简介：
We explore how the Patent Office may improve the quality of issued patents on secondary drug features by giving examiners more time to review drug-patent applications. Our findings suggest that current time allocations are causing examiners to issue low quality secondary patents on the margin. To
提供机构：
美国国家经济研究局
创建时间：
2020-07-01
